Lumos Pharma (LUMO) Stock Chart & Stock Price History $1.80 +0.26 (+16.88%) (As of 07/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lumos Pharma Stock Price Performance5 Day Performance+24.66%1 Month Performance-19.46%3 Month Performance-35.57%6 Month Performance-36.69%Year-To-Date Performance-42.76%1 Year Performance-44.00% Receive LUMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.I have uncovered a bombshell that changes everything… and threatens everything. LUMO Stock Chart for Saturday, July, 27, 2024 LUMO Chart by TradingView Lumos Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2024$1.54$1.54$1.58$1.538,255 shs$12.51 million07/24/2024$1.53$1.54+0.65%$1.57$1.4614,189 shs$12.51 million07/23/2024$1.47$1.53+4.08%$1.53$1.4460,754 shs$12.42 million07/22/2024$1.46$1.47+0.68%$1.57$1.4520,112 shs$11.94 million07/19/2024$1.45$1.46+0.69%$1.53$1.467,491 shs$11.86 million07/18/2024$1.50$1.45-3.33%$1.56$1.4054,156 shs$11.77 million Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/17/2024$1.54$1.50-2.60%$1.57$1.4459,444 shs$12.18 million07/16/2024$1.55$1.54-0.65%$1.69$1.3976,832 shs$12.50 million07/15/2024$1.65$1.55-6.06%$1.70$1.5116,153 shs$12.59 million07/12/2024$1.77$1.65-6.78%$1.87$1.5581,564 shs$13.40 million07/11/2024$1.73$1.77+2.31%$1.84$1.6452,398 shs$14.37 million07/10/2024$1.78$1.73-2.81%$1.91$1.3763,201 shs$14.05 million07/09/2024$2.18$1.78-18.35%$2.15$1.75229,494 shs$14.45 million07/08/2024$2.21$2.18-1.36%$2.23$2.152,001 shs$17.70 million07/05/2024$2.20$2.21+0.45%$2.21$2.202,380 shs$17.95 million07/04/2024$2.20$2.20$2.28$2.202,183 shs$17.86 million07/03/2024$2.27$2.20-3.08%$2.28$2.202,183 shs$17.86 million07/02/2024$2.26$2.27+0.31%$2.32$2.1712,201 shs$18.43 million07/01/2024$2.32$2.26-2.46%$2.38$2.2523,980 shs$18.38 million06/28/2024$2.27$2.32+2.20%$2.32$2.25951 shs$18.83 million06/27/2024$2.26$2.27+0.44%$2.28$2.232,528 shs$18.43 million06/26/2024$2.24$2.26+0.89%$2.28$2.253,038 shs$18.35 million06/25/2024$2.27$2.24-1.32%$2.34$2.213,925 shs$18.19 million06/24/2024$2.23$2.27+1.79%$2.36$2.204,894 shs$18.43 million06/21/2024$2.19$2.23+1.83%$2.23$2.0925,510 shs$18.11 million06/20/2024$2.20$2.19-0.45%$2.24$2.1511,197 shs$17.78 million06/19/2024$2.20$2.20$2.32$2.1713,334 shs$17.86 million06/18/2024$2.30$2.20-4.35%$2.32$2.1713,334 shs$17.86 million06/17/2024$2.39$2.30-3.77%$2.43$2.303,336 shs$18.68 million06/14/2024$2.48$2.37-4.44%$2.52$2.3613,172 shs$19.24 million06/13/2024$2.51$2.48-1.20%$2.58$2.461,909 shs$20.14 million06/12/2024$2.55$2.51-1.57%$2.57$2.468,668 shs$20.38 million06/11/2024$2.41$2.55+5.81%$2.60$2.248,764 shs$20.71 million06/10/2024$2.48$2.41-2.82%$2.67$2.2825,868 shs$19.57 million06/07/2024$2.51$2.48-1.20%$2.51$2.435,338 shs$20.14 million06/06/2024$2.35$2.51+6.81%$2.52$2.3521,712 shs$20.38 million06/05/2024$2.27$2.35+3.52%$2.40$2.304,638 shs$19.08 million06/04/2024$2.30$2.27-1.30%$2.38$2.1024,129 shs$18.43 million06/03/2024$2.25$2.30+2.22%$2.37$2.2610,006 shs$18.68 million05/31/2024$2.29$2.25-1.75%$2.44$2.2513,215 shs$18.26 millionNvidia insiders dumping shares (Ad)All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.To see Porter Stansberry's new AI prediction go here now.05/30/2024$2.31$2.29-0.87%$2.37$2.2420,737 shs$18.60 million05/29/2024$2.31$2.31$2.39$2.306,985 shs$18.76 million05/28/2024$2.45$2.31-5.71%$2.44$2.3022,402 shs$18.76 million05/27/2024$2.45$2.45-0.04%$2.52$2.2865,500 shs$19.89 million05/24/2024$2.51$2.45-2.35%$2.52$2.2865,433 shs$19.90 million05/23/2024$2.55$2.51-1.57%$2.63$2.3515,943 shs$20.38 million05/22/2024$2.52$2.55+1.19%$2.66$2.526,495 shs$20.71 million05/21/2024$2.62$2.52-3.82%$2.64$2.5015,132 shs$20.45 million05/20/2024$2.54$2.62+3.15%$2.70$2.5251,647 shs$21.27 million05/17/2024$2.63$2.54-3.42%$2.64$2.427,451 shs$20.63 million05/16/2024$2.24$2.63+17.41%$2.67$2.2244,100 shs$21.35 million05/15/2024$2.55$2.24-12.16%$2.45$2.02137,953 shs$18.19 million05/14/2024$2.86$2.55-10.84%$2.89$2.4483,487 shs$20.71 million05/13/2024$2.90$2.86-1.38%$2.93$2.7610,964 shs$23.22 million05/10/2024$3.02$2.92-3.31%$3.05$2.7332,788 shs$23.71 million05/09/2024$3.00$3.02+0.67%$3.19$2.9931,235 shs$24.52 million05/08/2024$3.02$3.00-0.66%$3.03$2.9612,524 shs$24.36 million05/07/2024$3.00$3.02+0.67%$3.07$2.9226,477 shs$24.52 million05/06/2024$2.96$3.00+1.35%$3.05$2.9142,163 shs$24.35 million05/03/2024$3.04$2.96-2.63%$3.05$2.9069,636 shs$24.04 million05/02/2024$3.02$3.04+0.66%$3.06$2.98125,196 shs$24.69 million05/01/2024$2.87$3.02+5.23%$3.07$2.73270,583 shs$24.51 million04/30/2024$2.89$2.87-0.69%$2.90$2.7019,517 shs$23.30 million04/29/2024$2.77$2.89+4.33%$2.92$2.7713,699 shs$23.47 million04/26/2024$2.76$2.83+2.36%$2.83$2.74688 shs$22.94 million04/25/2024$2.82$2.76-2.13%$2.81$2.711,569 shs$22.41 million Related Companies: NextCure Stock Chart Tempest Therapeutics Stock Chart Vaxxinity Stock Chart Lantern Pharma Stock Chart Kezar Life Sciences Stock Chart Nabriva Therapeutics Stock Chart Cue Biopharma Stock Chart DURECT Stock Chart ProMIS Neurosciences Stock Chart Fortress Biotech Stock Chart Receive LUMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUMO) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lumos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.